Phase-3 trials of indigenous COVAXIN initiated in Kanpur
Kanpur initiates phase 3 trials of India's first indigenous vaccine, COVAXIN after a thorough inspection of arrangements by the Bharat ...
Kanpur initiates phase 3 trials of India's first indigenous vaccine, COVAXIN after a thorough inspection of arrangements by the Bharat ...